ArticleTransplantation and cellular therapy2021

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.

Betül Oran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.